Rufinamide
Indication
Adjunct treatment of seizures in Lennox-Gastaut syndrome
MHRA Drug Safety Update - Antiepileptic drugs: updated advice on switching between different manufacturers’ products
Amber level 0
Brand:
Inovelon®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: